Richard Lewis will describe his experience as the nation's leading technical expert on drug card programs from[masked], and his role designing and implementing programs for Pfizer, Merck, Eli Lilly, and eventually the Medicare Part D program itself. He will step through the confusing and carefully crafted path that began in 2001 and resulted in legislation with mechanisms for pharmacuetical corporations to reap profits of tens of billions of taxpayer dollars per year.
In 2003, the Bush administration aggressively pushed for the creation of Medicare Part D, a subsidized drug benefit program for seniors and people with disabilities. The program was passed with The Medicare Modernization Act of 2003. In the preceding years, the pharmacuetical industry spent billions of dollars on lobbying efforts and developing precursor discount drug card programs.
We'll go to the Blue Moose afterwards.